NIH Archives - Page 2 of 6 - Friends of the National Institute on Aging

NIA Office of Legislation, Policy, and International Activities (OLPIA) Office Hours

The NIA Office of Legislation, Policy, and International Activities (OLPIA) will hold the first in a new series of virtual “OLPIA Office Hours” on Friday, May 5, from 1:00—2:00 pm ET. Each OLPIA Office Hour will open with a presentation from an NIA expert, followed by an office hour-style segment guided by your questions and interests regarding the talk or any other questions for OLPIA staff. The May 5^th Office Hour will feature a presentation from Dr. Coryse St. Hillaire-Clarke, who will discuss associations between vision impairment and dementia. To register, please visit the online registration site.

FY 2024 Alzheimer’s Disease and Related Dementias Bypass Budget Released

At today’s meeting of the Advisory Council on Alzheimer’s Research, Care, and Services, NIA Director Dr. Richard Hodes presented the NIH FY 2024 Professional Judgment Budget, “Looking Forward: Opportunities to Accelerate Alzheimer’s and Related Dementias Research.” For FY 2024, the content and structure of the Professional Judgment Budget, or “Alzheimer’s Disease Bypass Budget” (ADBB), have been updated. Previous ADBB narratives focused on scientific accomplishments in AD/ADRD research. The FY 2024 ADBB narrative outlines examples of prospective research opportunities that could be supported with additional funds in FY 2024. Examples of future research opportunities are organized across six broad scientific categories:

Epidemiology/Population Studies
Disease Mechanisms
Diagnosis, Assessment, & Disease Monitoring
Translational Research & Clinical Interventions
Dementia Care & Impact of Disease
Research Resources

The FY 2024 ADBB also emphasizes significant cross-cutting research efforts centered on health equity and inclusion. For FY 2024, additional NIH resources needed for new Alzheimer’s and related dementias research are $321 million, which would bring the total FY 2024 NIH resource needs for AD/ADRD research to $3.87 billion.

NIA’s Office of Legislation, Policy, and International Activities will hold a webinar for stakeholders on Thursday, August 11^th, from 11:00 am—12:00 pm ET to review the FY 2024 ADBB and answer any questions you may have. To register, please visit the webinar registration page.

#ResearchDiversity Day – October 21st

Join NIA and other institutes across NIH to celebrate #ResearchDiversity Day. The event will take place on October 21^st from 1:00-2:00 PM ET. This year, NIA will focus on diversity supplements and the grantees who have been awarded them. Follow along on Twitter using #ResearchDiversity to hear directly from awardees about their research, experiences, and how having a diversity supplement has helped advance their research careers.

NIH Hosts Science of Sleep Across the Lifespan Q&A Series

NIH will host the Science of Sleep Across the Lifespan Q&A Series on Facebook, which will provide information on how sleep impacts the health of teens, adults, and older adults. Each event will also be archived to view later.

The Science of Sleep and Teens (hosted by NICHD) – view August 10th archived event
The Science of Sleep and Adults (hosted by NHLBI) – August 17^th at 2:30PM ET
The Science of Sleep and Older Adults (hosted by NIA) – August 24^th at 2:30PM ET

FY2023 NIH Professional Judgement Budget for Alzheimer’s Disease and Related Dementias

In a recent InsideNIA blog post, NIA Director Dr. Richard Hodes highlighted the newly released FY 2023 NIH Professional Judgment Budget for Alzheimer’s Disease and Related Dementias, also known as the “bypass budget.” The report, titled Transforming Research to Prevent, Detect, Treat, and Provide Better Care for Dementia, features summaries of key studies in Alzheimer’s and related dementias (AD/ADRD) research and the tremendous progress of NIA scientists and grantees in this area. In addition, the FY 2023 bypass budget identifies $226 million in additional resources needed for new AD/ADRD research to help reach the goal of the National Plan to Address Alzheimer’s Disease – to effectively treat and prevent these diseases by 2025.